News | April 26, 2024
Merck 1Q 2024 sales up 9% to US$ 15.8 billion
Sales reflect continued strong growth in oncology and vaccines
Sales reflect continued strong growth in oncology and vaccines
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
The demand in Africa for COVID-19 vaccines has declined
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Subscribe To Our Newsletter & Stay Updated
